首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1741263

支气管扩张药物市场按药物类别、给药途径、分销管道和地区划分

Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

支气管扩张药物市场规模预计在 2025 年为 4.069 亿美元，预计到 2032 年将达到 8.031 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	4.069亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	10.20%	2032年价值预测	8.031亿美元

支气管扩张症是一种肺部管道（气道）因损伤而扩张或形成囊状的疾病。支气管扩张症使肺部黏液难以排放，导致频繁感染疾病。支气管扩张症的主要症状是咳嗽，伴随脓液或黏液。支气管扩张症无法治愈，但可以透过治疗进行控制。

支气管扩张症是一种以气道扩张为特征的慢性呼吸系统疾病，治疗支气管扩张症的药物对于控制其症状和併发症至关重要。这些药物旨在缓解慢性咳嗽、过多黏液分泌和反覆呼吸道感染疾病等症状，同时减缓病情进展。治疗支气管扩张症的药物包括支气管扩张剂、黏液清除剂、抗生素和抗发炎药物。这些进展为改善患者预后和生活品质开闢了新的可能性。正在进行的支气管扩张症研究正在探索新的治疗方法和标靶药物，这为更有效的治疗和更好的疾病管理带来了希望。

市场动态：

预测期内，支气管扩张症盛行率的上升、治疗方案的进步以及对个人化医疗的日益关注预计将推动全球支气管扩张症药物市场的成长。此外，有利的法规环境和市场参与者研发活动的活性化预计将推动市场在预测期内的成长。

例如，2022年2月，生物技术公司Armata Pharmaceuticals, Inc.宣布，美国食品药物管理局（FDA）已核准Armata的临床实验（IND）申请，以启动其优化的领先治疗候选药物AP-PA02的临床试验，用于治疗第二种适应症－非囊肿纤维化支气管扩张。

本研究的主要特点

本报告对全球支气管扩张药物市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率(CAGR)，以 2024 年为基准年。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，介绍了全球支气管扩张药物市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球支气管扩张药物市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球支气管扩张治疗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 406.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.20%	2032 Value Projection:	USD 803.1 Mn

Bronchiectasis is a condition where damage causes the tubes in your lungs (airways) to widen or develop pouches. It makes it hard to clear mucus out of your lungs and can cause frequent infections. Coughing a lot with pus and mucus is the main symptom of bronchiectasis. Bronchiectasis can't be cured but can be managed with treatment.

Bronchiectasis drugs are essential for managing the symptoms and complications of bronchiectasis, a chronic respiratory condition characterized by widening of the bronchial tubes. These drugs aim to alleviate symptoms like chronic cough, excessive mucus production, and recurrent respiratory infections while slowing down disease progression. Bronchiectasis drugs encompass bronchodilators, mucus-clearing agents, antibiotics, and anti-inflammatory medicine. Their development has opened new possibilities for improved patient outcomes and quality of life. Ongoing research in bronchiectasis explores novel therapeutic approaches and targeted medications, offering hope for more effective treatments and better disease management.

Market Dynamics:

The increasing prevalence of bronchiectasis, advancements in treatment options, and increasing focus on personalized medicine are anticipated to drive growth of the global bronchiectasis drugs market over the forecast period. Moreover, a supportive regulatory environment and increased research and developmental activities by market players is expected to drive market growth over the forecast period.

For instance, in February 2022, Armata Pharmaceuticals, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared Armata's Investigational New Drug (IND) application to initiate a clinical trial of its optimized lead therapeutic candidate, AP-PA02, in a second indication, non-cystic fibrosis bronchiectasis.

Key features of the study:

This report provides in-depth analysis of the global bronchiectasis drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchiectasis drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, Sunovion Pharmaceuticals, Chiesi Farmaceutici
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bronchiectasis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchiectasis drugs market

Detailed Segmentation:

Bronchiectasis drugs market, By Drug Class:
- Antibiotics
- Mucolytics
- Bronchodilators
- Anti-inflammatory agents
Bronchiectasis drugs market, By Route of Administration:
- Oral
- Inhalation
- Intravenous
Bronchiectasis drugs market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Bronchiectasis drugs market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Bayer AG
- GlaxoSmithKline
- Boehringer Ingelheim
- Novartis
- AstraZeneca
- Sunovion Pharmaceuticals
- Chiesi Farmaceutici

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bronchiectasis Drugs, By Drug Class
- Market Bronchiectasis Drugs, By Route of Administration
- Market Bronchiectasis Drugs, By Distribution Channel
- Market Bronchiectasis Drugs, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Bronchiectasis
Increasing Awareness of the Disease
- Restraints
Limited Awareness and Underdiagnoses
Lack of Specific Treatment Guidelines
- Opportunities
Unmet Medical Needs
Emerging Markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bronchiectasis Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bronchiectasis Drugs Market, By Drug Class, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Mucolytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Anti-inflammatory agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Bronchiectasis Drugs Market, By Route of Administration, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Bronchiectasis Drugs Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Bronchiectasis Drugs Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - China
  - Japan
  - India
  - South Korea
  - ASEAN
  - Australia
  - Rest of Middle East
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Bayer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

支气管扩张药物市场按药物类别、给药途径、分销管道和地区划分